Milind Deshpande

2014

In 2014, Milind Deshpande earned a total compensation of $4.9M as Director, President and Chief Executive Officer at Achillion Pharmaceuticals, a 16% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$384,860
Option Awards$4,070,653
Salary$484,100
Other$8,124
Total$4,947,737

Deshpande received $4.1M in option awards, accounting for 82% of the total pay in 2014.

Deshpande also received $384.9K in non-equity incentive plan, $484.1K in salary and $8.1K in other compensation.

Rankings

In 2014, Milind Deshpande's compensation ranked 1,586th out of 13,032 executives tracked by ExecPay. In other words, Deshpande earned more than 87.8% of executives.

ClassificationRankingPercentile
All
1,586
out of 13,032
88th
Division
Manufacturing
567
out of 4,966
89th
Major group
Chemicals And Allied Products
181
out of 1,686
89th
Industry group
Drugs
141
out of 1,365
90th
Industry
Pharmaceutical Preparations
121
out of 1,043
88th
Source: SEC filing on April 17, 2017.

Deshpande's colleagues

We found four more compensation records of executives who worked with Milind Deshpande at Achillion Pharmaceuticals in 2014.

2014

David Apelian

Achillion Pharmaceuticals

Chief Medical Officer

2014

Joseph Truitt

Achillion Pharmaceuticals

Executive Vice President and Chief Commercial Officer

2014

Mary Fenton

Achillion Pharmaceuticals

Chief Financial Officer

2014

Gautam Shah

Achillion Pharmaceuticals

Former Executive Vice President and Chief Compliance Officer

News

In-depth

You may also like